References

Ashwood, E.R., 1999. Clinical Chemistry of Pregnancy. In: Textbook of Clinical Chemistry, Burtis, C.A. and E.R. Tietz, WB Saunders, Philadelphia, pp: 1736-1775.

Bogart, M.H., M.R. Pandian and O.W. Jones, 1987. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat. Diagn., 7: 623-630.
CrossRef  |  

Canick, J.A., G.J. Knight, G.E. Palomaki, J.E. Haddow, H.S. Cuckle and N.J. Wald, 1988. Low second trimester maternal serum unconjugated oesteriol in pregnancies with Downs syndrome. BJOG Int. J. Obstet. Gynaecol., 95: 330-333.
CrossRef  |  

Cuckle, H., 1995. Improved parameters for risk estimation in Downs syndrome screening. Prenat. Diagn., 15: 1057-1065.
CrossRef  |  

Dunstan, F.D., T.C. Iles, A.B. Nix and K. Williams, 1999. Correlation of marker values in Downs syndrome screening: The effect of dating error. Ann. Clin. Biochem., 36: 460-467.
PubMed  |  

Forest, J.C., J. Masse, F. Rousseau, J.M. Moutquin, N.A. Brideau and M. Belanger, 1995. Screening for Down syndrome during the first and second trimesters: Impact of risk estimation parameters. Clin. Biochem., 28: 443-449.
PubMed  |  

Hall, J.G., 2000. Chromosomal Clinical Abnormalities. In: Nelson Textbook of Pediatrics, Behrman, R.E. and R.M. Kliegman and H.B. Jenson (Eds.). WB Saunders, Philadelphia, pp: 325-332.

Merkatz, I.R., H.M. Nitowsky, J.N. Macri and W.E. Johnson, 1984. An associatin between low maternal serum a-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol., 148: 886-894.
PubMed  |  

Neveux, L.M., G.E. Palomaki, D.A. Larrivee, G.J. Knight and J.E. Haddow, 1996. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat. Diagn., 16: 1115-1119.
CrossRef  |  

Palomaki, G.E. and J.E. Haddow, 1987. Maternal serum alpha-fetoprotein, age and Down syndrome risk. Am. J. Obstet. Gynecol., 156: 460-463.
PubMed  |  

Reynolds, T.M. and M.D. Penny, 1989. The mathematical basis of multivariate risk screening: With special reference to screening for Downs syndrome associated pregnancy. Ann. Clin. Biochem., 27: 452-458.
PubMed  |  

Wald, N.J., H.S. Cuckle, J.W. Densem, A. Kennard and D. Smith, 1992. Maternal serum screening for Downs syndrome: The effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br. J. Obstet. Gynaecol., 99: 144-149.
PubMed  |  

Wald, N.J., H.S. Cuckle, J.W. Densem, K. Nanchahal and J.A. Canick et al., 1988. Maternal serum unconjugated oesteriol as an antenatal screening test for Downs syndrome. Br. J. Obstet. Gynaecol., 95: 334-341.
PubMed  |  

Wald, N.J., H.S. Cuckle, J.W. Densem, K. Nanchahal and P. Royston et al., 1988. Maternal serum screening for Downs syndrome in early pregnancy. BMJ, 297: 883-887.
Direct Link  |  

Wald, N.J., J.W. Densem, D. Smith and G.G. Klee, 1994. Four marker serum screening for Downs syndrome. Prenat. Diagn., 14: 707-716.
PubMed  |  

Williams, K.L., B.A.J. Nix and F.D.J. Dunstan, 2000. Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Downs syndrome screening. Ann. Clin. Biochem., 37: 165-173.
CrossRef  |